1066
H. Matsuda et al. / Bioorg. Med. Chem. Lett. 13 (2003) 1063–1066
all protective groups of tetramer 30 were successfully
removed by employing the methodology described
above (NaOMe in methanol, followed by DDQ in aqu-
eous CH2Cl2), giving free sulfur substituted methyl iso-
maltotetraoside 1 in 65% yield (two steps).19 The
tetrameric structure of 1 was confirmed by the observa-
tion of four signals of equatorial oriented anomeric
protons at d=4.79, 4.82, 4.83, and 4.88 ppm (J=2.9,
13. Hashimoto, H.;Izumi, M. Tetrahedron Lett. 1993, 34,
4949.
14. Deprotection under Birch’s conditions was not examined.
15. Oikawa, Y.;Yoshioka, T.;Yonemitsu, O.
Tetrahedron
Lett. 1982, 23, 885.
16. Spectral data, 20: 1H NMR (400 MHz, D2O, 38 ꢁC) d 3.05
(1H, m, C05H), 3.42 (3H, s, C1OCH3), 3.59 (1H, dd, J=3.9,
9.7 Hz, C2H), 3.62–3.67 (2H, C03H, C04H), 3.73–3.77 (2H,
C4H, C5H), 3.82–3.85 (2H, C02H, C6H), 3.88–3.90 (3H, C06H
ꢂ2, C6H), 3.95 (1H, t, J=9.7 Hz, C3H), 4.81 (1H, d,
J=3.9 Hz, C1H), 5.33 (1H, d, J=3.4 Hz, C01H). 13C NMR
(100 MHz, D2O, 38 ꢁC) d 43.9 (C05), 55.2 (C1OCH3), 60.2
(C06), 61.0 (C6), 70.2 (C5), 71.3 (C2), 73.4 (C04), 73.9 (C03),
74.1 (C3), 75.5 (C2), 75.6 (C4), 82.8 (C01), 99.2 (C1). FAB-MS
(%, rel. int.) 371 ([MꢀH]ꢀ, 100): HR-MS (FAB, negative)
calcd for C13H23O10S [MꢀH]ꢀ: 371.1012, found m/z
1
2.9, 2.9, and 3.9 Hz, respectively) in the H NMR spec-
trum as well as the molecular ion peak at m/z=727
([MꢀH]ꢀ) by FAB-MS (negative mode). Further, the
13C NMR spectrum (25 carbons) fully supported the
structure of 1.
As described in this report, we have developed a general
a-stereoselective glycosylation employing 5-thiogluco-
pyranoses as well as a deprotection protocol that is
applicable to the resulting oligothiosaccharides. Studies
on the enzyme binding properties of 1 and the synthesis
of additional oligothiosaccharides are under investi-
gation in our laboratory.
=371.0975. 21: H NMR (400 MHz, D2O, 38 ꢁC) d 3.10 (1H,
1
ddd, J=3.4, 4.9, 10.3 Hz, C05H), 3.43 (3H, s, C1OCH3), 3.49
(1H, dd, J=9.0, 10.0 Hz, C4H), 3.57 (1H, dd, J=3.9, 9.7 Hz,
C2H), 3.64 (1H, dd, J=8.8, 10.2 Hz, C04H), 3.67 (1H, dd,
J=9.0, 9.7 Hz, C3H), 3.69 (1H, dd, J=8.8, 9.3 Hz, C03H), 3.72
(1H, dd, J=2.0, 11.0 Hz, C6H), 3.83 (1H, m, C5H), 3.85 (1H,
dd, J=2.9, 9.3 Hz, C02H), 3.87 (1H, dd, J=3.4, 11.4 Hz,
C06H), 3.92 (1H, dd, J=4.9, 11.4 Hz, C06H), 4.13 (1H, dd,
J=4.6, 11.2 Hz, C6H), 4.77 (1H, d, J=3.0 Hz, C01H), 4.82
(1H, d, J=3.9 Hz, C1H). 13C NMR (100 MHz, D2O, 38 ꢁC) d
43.1 (C05), 55.3 (C1OCH3), 60.2 (C06), 66.6 (C6), 69.7 (C4),
70.2 (C5), 71.3 (C2), 73.5 (C04), 73.6 (C3), 74.2 (C03), 75.4
(C02), 81.9 (C01), 99.4 (C1). FAB-MS (%, rel. int.) 371
([MꢀH]ꢀ, 21), HR-MS (FAB, negative) calcd for C13H23O10S
[MꢀH]ꢀ: 371.1012, found m/z 371.1000.
Acknowledgements
We would like to thank Professor Jun Kawabata and
Dr. Eri Fukushi of Hokkaido University for measure-
ments of mass spectra and for fruitful discussions. We
are grateful to Dr. Craig A. Parish of Merck Research
Laboratories for kindly reading and correcting this
manuscript.
17. Schmidt, R. R. Angew. Chem., Int. Ed. Engl. 1986, 25,
212.
18. Deprotection of EE group in 24 was performed by
sequential operations of (i) stirring in EtOH in the pre-
sence of PPTS for 30 min, (ii) evaporation of the mixture,
and (iii) stirring for 2 h after dilution with PrOH. Sub-
strate 24 was insoluble in EtOH. The reactions in PrOH
or in a mixed solvent system (PrOH:EtOH=3:1) were less
effective.
19. A solution of 30 (11.5 mg, 5.10 mmol) in MeOH (2.0 mL)
was stirred with NaOMe (2.5 mg, 46.3 mmol) at room tem-
perature for 1 h. The mixture was neutralized by the addition
of DOWEX 50W (H+ form), filtered, and concentrated in
vacuo. Without further purification, the residue was stirred
with DDQ (46.2 mg, 204 mmol) in a mixture of CH2Cl2
(1.0 mL) and H2O (100 mL) at room temperature for 12 h.
After concentration, the residue was purified by silica gel col-
References and Notes
1. Glycoscience; Synthesis of Substrate Analogues and Mimet-
ics. Driguez, H., Thiem, J. Eds. Springer: Berlin, 1999.
2. Glycoscience; Synthesis of Oligosaccharides and Glyco-
conjugates. Driguez, H., Thiem, J. Eds. Springer: Berlin, 1999.
3. Witczak, Z. J. Curr. Med. Chem. 1999, 6, 165.
4. Spohr, U.;Bach, M.;Spiro, R. G. Can. J. Chem. 1993, 71,
1919.
5. Gurjar, M. K.;Nagaprasad, R.;Ramana, C. V.
hedron Lett. 2002, 43, 7577.
Tetra-
6. Davies, G. J.;Wilson, K. S.;Henrissat, B.
1997, 321, 557.
7. Shimizu, T.;Nakatsu, T.;Miyairi, K.;Okuno, T.;Kato, H.
Biochemistry 2002, 41, 6651.
8. Dondoni, A.;Marra, A.;Mizuno, M.;Ciovannini, P. P. J.
Org. Chem. 2002, 67, 4186.
9. PC Spartan Pro version 1.0.8 by wavefunction Ltd.Co.
10. Yuasa, H.;Hashimoto, H. Rev. Heteroatom Chem. 1999,
19, 35.
11. Mehta, S.;Jordan, K. L.;Weimar, T.;Kreis, U. C.;
Batchelor, R. J.;Einstein, F. W. B.;Pinto, B. M. Tetrahedron:
Asymmetry 1994, 5, 2367.
12. Izumi, M.;Suhara, Y.;Ichikawa, Y. J. Org. Chem. 1998,
63, 4811.
Biochem. J.
umn chromatography (MeOH/AcOEt=40:60) to give 1
(2.4 mg, 65% in two steps). 1H NMR (400 MHz, D2O, 43 ꢁC) d
3.24 (1H, brddd, J=3.4, 4.8, 9.8 Hz), 3.32–3.37 (1H, m), 3.39–
3.44 (1H, m), 3.50 (3H, s), 3.56 (1H, t, J=9.8 Hz), 3.64 (1H,
dd, J=3.9, 9.8 Hz), 3.67–3.79 (7H), 3.87–4.00 (9H), 4.10–4.17
(2H), 4.22 (1H, dd, J=4.9, 9.8 Hz), 4.79 (1H, d, J=2.9 Hz),
4.82 (1H, d, J=2.9 Hz), 4.83 (1H, d, J=2.9 Hz), 4.88 (1H, d,
J=3.9 Hz). 13C NMR (100 MHz, D2O) d 40.8 (d), 40.9 (d),
43.3 (d), 55.4 (q), 66.7 (t), 60.3 (t), 66.9 (t), 67.0 (t), 69.8 (d),
70.2 (d), 71.4 (d), 73.6 (d), 73.7 (d), 74.23 (d), 74.25 (d), 74.31
(d), 74.32 (d), 74.34 (d), 75.28 (d), 75.34 (d), 75.40 (d), 81.68
(d), 81.71 (d), 81.92 (d), 99.5 (d). FAB-MS (%, rel. int.) 727
([MꢀH]ꢀ, 19), HR-MS (FAB, negative) calcd for C25H43O18S3
[MꢀH]ꢀ: 727.1612, found m/z 727.1591.